Description
Montelukast sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor, stimulation of which by circulating leukotrienes is thought to play a role in the pathogenesis of asthma. It supresses both early and late bronchoconstrictor responses to inhaled antigens or irritations, but is not suitable for the management of acute attacks of asthma.
Reviews
There are no reviews yet.